rss
Br J Ophthalmol 88:17-18 doi:10.1136/bjo.88.1.17
  • Clinical science
    • Scientific reports

Mitomycin C as an adjunct in the treatment of localised ocular surface squamous neoplasia

Table 1

Details of treatment and follow up for the 27 primary OSSN cases

Patient Age of Dx R/L eye Location Histopathology Complications Treatment No of course (MMC S/e) Follow up (months) Recurrence
E  =  excision, C  =  cryotherapy, MMC  =  mitomycin C, CIN  =  conjunctival intra-epithelial neoplasia.
1 56 R Temporal limbal CIN I Granuloma E, MMC 3 Nil 20 No
2 75 L Temporal limbal CIN I E, C, MMC 3 nil 33 No
3 86 R Limbal CIN III E, C, MMC 3 Nil 12 No
4 57 R Nasal limbal CIN I E, MMC 2 Allergy 38 No
5 52 L Nasal limbal CIN II E, C, MMC 3 Nil 40 No
6 57 R Nasal limbal CIN I E, MMC 2 Allergy 36 No
7 57 R Inferonasal limbal CIN I E, C, MMC 2 Allergy 41 No
8 61 R Nasal limbal CIN II E, MMC 2 Allergy 20 No
9 53 R Nasal limbal CIN III Granuloma E, C, MMC 3 Nil 20 No
10 62 R Nasal limbal CIN I Nil E, C, MMC 3 Nil 29 No
11 50 L Nasal limbal CIN III E, C, MMC 3 Itch 7 No
12 53 R Nasal limbal CIN II E, C, MMC 3 Nil 14 No
13 69 R Limbal CIN I E, C, MMC 3 Nil 50 No
14 70 R Nsal CIN II E, MMC 2 Allergy 42 No
15 41 R Temporal limbal CIN I Granuloma E, C, MMC 3 Nil 26 No
16 63 L Temporal CIN III E, C, MMC 2 Allergy 17 No
17 61 R Nasal limbal CIN I E, MMC 2 Allergy 40 No
18 75 L Temporal limbal CIN I Granuloma E, MMC 3 Nil 37 No
19 76 R Limbal CIN I E, MMC 3 Nil 25 No
20 57 L Temporal limbal CIN III E, C, MMC 3 Nil 25 No
21 82 L Temporal limbal CIN III E, C, MMC 3 Nil 20 No
22 49 L Nasal limbal CIN III E, MMC 3 Nil 40 No
23 47 R Nasal CIN II Granuloma E, C, MMC 2 Allergy 23 No
24 73 R Nasal limbal CIN III E, MMC 3 Nil 22 No
25 67 L Temporal CIN I Nil E, C, MMC 3 Nil 24 No
26 87 L Limbal base CIN III E, C, MMC 3 Nil 10 No
27 82 R Limbal CIN I E, C, MMC 3 Nil 13 No

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.